{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:36:48Z","timestamp":1780087008432,"version":"3.54.0"},"update-to":[{"DOI":"10.1002\/14651858.cd013167","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000}}],"reference-count":203,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013167.pub2","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T10:07:47Z","timestamp":1641809267000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer"],"prefix":"10.1002","volume":"2022","author":[{"given":"Kate E","family":"Roberts","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology; Princess Alexandra Hospital; Woolloongabba Australia"},{"name":"School of Clinical Medicine, Mater Clinical Unit; Mater Hospital, University of Queensland; South Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"India T","family":"Adsett","sequence":"additional","affiliation":[{"name":"Ipswich Hospital, Queensland Health; Ipswich Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"Rickett","sequence":"additional","affiliation":[{"name":"The University of Queensland Library; UQ\/Mater McAuley Library; Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie M","family":"Conroy","sequence":"additional","affiliation":[{"name":"Medical Oncology; Mater Health; Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D","family":"Chatfield","sequence":"additional","affiliation":[{"name":"Centre for Health Services Research; The University of Queensland; Woolloongabba Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha E","family":"Woodward","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Mater Clinical Unit; Mater Hospital, University of Queensland; South Brisbane Australia"},{"name":"Department of Medical Oncology; Mater Misericordiae Ltd; South Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,1,10]]},"reference":[{"issue":"24 Suppl","key":"10.1002\/14651858.CD013167.pub2-BIB0001|cit1","first-page":"Abstract no. 80","article-title":"Testosterone undecanoate treatment reduces joint morbidities induced by anastrozole therapy in postmenopausal women with breast cancer: results of a double-blind, randomized phase II trial","volume":"69","author":"Birrell","year":"2009","journal-title":"Cancer Research"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0002|cit2","unstructured":"Birrell SN Reduction of side effects from aromatase inhibitors used for treating breast cancer United States Patent Application Publication US 2012\/0122824 A1"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0003|cit3","unstructured":"Androgen therapy for breast cancer patients with aromatase inhibitor induced side effects clinicaltrials.gov\/show\/NCT00497458"},{"issue":"1","key":"10.1002\/14651858.CD013167.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00520-020-05473-2.","article-title":"A randomized, double-blind, placebo controlled trial of testosterone for treatment of postmenopausal women with aromatase inhibitor-induced arthralgias: Alliance study A221102","volume":"29","author":"Cathcart-Rake","year":"2020","journal-title":"Supportive Care in Cancer"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD013167.pub2-BIB0005|cit5","first-page":"P4","article-title":"A randomized, double-blind, placebo-controlled trial of testosterone (T) for aromatase inhibitor-induced arthralgias (AIA) in postmenopausal women: Alliance A221102","volume":"79","author":"Leon-Ferre","year":"2019","journal-title":"Cancer Research"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0006|cit6","unstructured":"Testosterone in treating postmenopausal patients with arthralgia caused by adjuvant aromatase inhibitor treatment clinicaltrials.gov\/show\/NCT01573442"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0007|cit7","unstructured":"Emu oil for joints pain in postmenopausal women with early breast cancer anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=336281"},{"issue":"12","key":"10.1002\/14651858.CD013167.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1007\/s00520-017-3810-9","article-title":"Randomized phase II placebo-controlled study to evaluate the efficacy of topical pure emu oil for joint pain related to adjuvant aromatase inhibitor use in postmenopausal women with early breast cancer: JUST (Joints Under Study)","volume":"25","author":"Chan","year":"2017","journal-title":"Supportive Care in Cancer"},{"issue":"4","key":"10.1002\/14651858.CD013167.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"326-32","DOI":"10.1200\/JCO.2017.74.6651","article-title":"Randomized, multicenter, placebo-controlled clinical trial of duloxetine versus placebo for aromatase inhibitor-associated arthralgias in early-stage breast cancer: SWOG S1202","volume":"36","author":"Henry","year":"2018","journal-title":"Journal of Clinical Oncology"},{"issue":"12","key":"10.1002\/14651858.CD013167.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/cncr.32024","article-title":"Association between body mass index and response to duloxetine for aromatase inhibitor-associated musculoskeletal symptoms in SWOG S1202","volume":"125","author":"Henry","year":"2019","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0011|cit11","unstructured":"S1202: duloxetine hydrochloride for muscle\/joint pain in early-stage breast cancer receiving hormone therapy clinicaltrials.gov\/show\/NCT01598298"},{"issue":"17","key":"10.1002\/14651858.CD013167.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1200\/JCO.2014.59.5595","article-title":"Randomized multicenter placebo-controlled trial of omega-3 fatty acids for the control of aromatase inhibitor-induced musculoskeletal pain: SWOG S0927","volume":"33","author":"Hershman","year":"2015","journal-title":"Journal of Clinical Oncology"},{"issue":"15 Suppl","key":"10.1002\/14651858.CD013167.pub2-BIB0013|cit13","first-page":"Abstract no. 95","article-title":"Omega-3 fatty acids for aromatase inhibitor-induced musculoskeletal symptoms in women with early-stage breast cancer (SWOG S0927)","volume":"32","author":"Hershman","year":"2014","journal-title":"Journal of Clinical Oncology"},{"issue":"24 Suppl","key":"10.1002\/14651858.CD013167.pub2-BIB0014|cit14","first-page":"Abstract no. OT","article-title":"SWOG S0927: a randomized double blind placebo-controlled trial of omega-3-fatty acid for the control of aromatase inhibitor (AI)-induced musculoskeletal pain in women with early stage breast cancer","volume":"71","author":"Hershman","year":"2011","journal-title":"Cancer Research"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0015|cit15","unstructured":"S0927: a randomized placebo-controlled trial of omega-3-fatty acid for the control of aromatase inhibitor-induced musculoskeletal pain and stiffness in women with early stage breast cancer, phase III clinicaltrials.gov\/ct2\/show\/NCT01385137"},{"issue":"3","key":"10.1002\/14651858.CD013167.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10549-018-4946-0","article-title":"Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927)","volume":"172","author":"Shen","year":"2018","journal-title":"Breast Cancer Research and Treatment"},{"issue":"15 Suppl","key":"10.1002\/14651858.CD013167.pub2-BIB0017|cit17","first-page":"Abstract no. 90","article-title":"Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms and fatigue in women with breast cancer starting adjuvant letrozole: the VITAL trial","volume":"30","author":"Khan","year":"2012","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD013167.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10549-017-4429-8","article-title":"Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial","volume":"166","author":"Khan","year":"2017","journal-title":"Breast Cancer Research and Treatment"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0019|cit19","unstructured":"Vitamin D3 for aromatase inhibitor induced arthralgias clinicaltrials.gov\/show\/NCT00867217"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0020|cit20","first-page":"Article ID 2478","article-title":"Traditional Chinese medicine bionic tiger bone powder for the treatment of AI-associated musculoskeletal symptoms","volume":"2017","author":"Li","year":"2017","journal-title":"Evidence-Based Complementary and Alternative Medicine"},{"issue":"3","key":"10.1002\/14651858.CD013167.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.4238\/2014.July.24.7","article-title":"Effect of calcitonin on anastrozole-induced bone pain during aromatase inhibitor therapy for breast cancer","volume":"13","author":"Liu","year":"2014","journal-title":"Genetics and Molecular Research"},{"issue":"9 Suppl","key":"10.1002\/14651858.CD013167.pub2-BIB0022|cit22","first-page":"Abstract no. P1","article-title":"Prevention of aromatase Inhibitor (AI)-induced joint symptoms with omega-3 fatty acid supplementation: a randomized placebo-controlled pilot study","volume":"75","author":"Lustberg","year":"2015","journal-title":"Cancer Research"},{"issue":"3","key":"10.1002\/14651858.CD013167.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10549-017-4559-z","article-title":"Randomized placebo-controlled pilot trial of omega 3 fatty acids for prevention of aromatase inhibitor-induced musculoskeletal pain","volume":"167","author":"Lustberg","year":"2018","journal-title":"Breast Cancer Research and Treatment"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0024|cit24","unstructured":"Omega-3 fatty acids in preventing joint symptoms in patients with stage I-III breast cancer receiving anastrozole, exemestane, or letrozole clinicaltrials.gov\/show\/NCT01478477"},{"issue":"9 Suppl","key":"10.1002\/14651858.CD013167.pub2-BIB0025|cit25","first-page":"Abstract no. 14","article-title":"Relationship of dietary and red blood cell polyunsaturated fatty acids to inflammatory markers in breast cancer survivors taking aromatase inhibitors","volume":"75","author":"Orchard","year":"2015","journal-title":"Cancer Research"},{"issue":"27 Suppl","key":"10.1002\/14651858.CD013167.pub2-BIB0026|cit26","first-page":"Abstract no. 17","article-title":"Use of Blue Citrus, a Chinese herbal remedy, to reduce side effects of aromatase inhibitors","volume":"29","author":"Massimino","year":"2011","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0027|cit27","unstructured":"Trial of Blue Citrus compared to placebo in patients receiving aromatase inhibitor therapy for estrogen receptor positive post-menopausal breast cancer clinicaltrials.gov\/show\/NCT00702858"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0028|cit28","unstructured":"High dose vitamin D vs standard dose vitamin D study clinicaltrials.gov\/ct2\/show\/NCT01988090"},{"issue":"2","key":"10.1002\/14651858.CD013167.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"427-35","DOI":"10.1007\/s10549-019-05319-4","article-title":"Randomized controlled trial of high-dose versus standard-dose vitamin D3 for prevention of aromatase inhibitor-induced arthralgia","volume":"177","author":"Niravath","year":"2019","journal-title":"Breast Cancer Research and Treatment"},{"issue":"19 Suppl","key":"10.1002\/14651858.CD013167.pub2-BIB0030|cit30","first-page":"Abstract no. CT","article-title":"A randomized, controlled trial of high dose vs. standard dose vitamin D for aromatase inhibitor-induced arthralgia in breast cancer survivors","volume":"74","author":"Niravath","year":"2014","journal-title":"Cancer Research"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0031|cit31","unstructured":"Traditional Chinese medicine for the management of aromatase inhibitor-associated musculoskeletal symptoms isrctn.com\/ISRCTN06129599"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.breast.2017.08.003","article-title":"Effects of the Chinese medicine Yi Shen Jian Gu granules on aromatase inhibitor-associated musculoskeletal symptoms: a randomized, controlled clinical trial","volume":"37","author":"Peng","year":"2018","journal-title":"Breast"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1745-6215-15-171","article-title":"Effects of the traditional Chinese medicine Yi Shen Jian Gu granules on aromatase inhibitor-associated musculoskeletal symptoms: a study protocol for a multicenter, randomized, controlled clinical trial","volume":"15","author":"Peng","year":"2014","journal-title":"Trials"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0034|cit34","unstructured":"High dose vit D musculoskeletal symptoms & bone density in anastrozole-treated breast cancer with marginal vit D status clinicaltrials.gov\/show\/NCT00263185"},{"issue":"24 Suppl","key":"10.1002\/14651858.CD013167.pub2-BIB0035|cit35","first-page":"Abstract no. 80","article-title":"A double-blind, randomized, placebo-controlled trial of high dose vitamin D therapy on musculoskeletal pain and bone mineral density in anastrozole-treated breast cancer patients with marginal vitamin D status","volume":"69","author":"Rastelli","year":"2010","journal-title":"Cancer Research"},{"issue":"1","key":"10.1002\/14651858.CD013167.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10549-011-1644-6","article-title":"Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial","volume":"129","author":"Rastelli","year":"2011","journal-title":"Breast Cancer Research and Treatment"},{"issue":"15 Suppl","key":"10.1002\/14651858.CD013167.pub2-BIB0037|cit37","first-page":"Abstract no. 53","article-title":"Etoricoxib and anastrozole in adjuvant early breast cancer: ETAN trial (phase III)","volume":"29","author":"Rosati","year":"2011","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0038|cit38","unstructured":"Vitamin D3 effects on musculoskeletal symptoms with use of aromatase inhibitors clinicaltrials.gov\/ct2\/show\/NCT01509079"},{"issue":"2","key":"10.1002\/14651858.CD013167.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10549-016-3818-8","article-title":"Erratum: randomized, blinded trial of vitamin D3\u00a0for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS)","volume":"157","author":"Shapiro","year":"2016","journal-title":"Breast Cancer Research and Treatment"},{"issue":"15 Supp","key":"10.1002\/14651858.CD013167.pub2-BIB0040|cit40","first-page":"Abstract no. 96","article-title":"A randomized trial of vitamin D3 in aromatase inhibitor-associated musculoskeletal symptoms","volume":"33","author":"Shapiro","year":"2015","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD013167.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10549-016-3710-6","article-title":"Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS)","volume":"155","author":"Shapiro","year":"2016","journal-title":"Breast Cancer Research and Treatment"},{"issue":"24 Suppl","key":"10.1002\/14651858.CD013167.pub2-BIB0042|cit42","first-page":"Abstract no. P5","article-title":"Vitamin D3 supplementation, musculoskeletal (MS) symptoms and aromatase inhibitor (AI) pharmacokinetics from the vitamin D3 AI study","volume":"73","author":"Shapiro","year":"2013","journal-title":"Cancer Research"},{"issue":"15 Suppl","key":"10.1002\/14651858.CD013167.pub2-BIB0043|cit43","first-page":"Abstract no. 52","article-title":"Effect of tart cherry on aromatase inhibitor-induced arthralgia (AIA) in nonmetastatic hormone-positive breast cancer patients: a randomized double-blind placebo-controlled trial","volume":"37","author":"Shenouda","year":"2019","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD013167.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"24","DOI":"10.18311\/jnr\/2019\/22867","article-title":"Randomized, double-blind, placebo-controlled phase ii clinical trial on the use of Uncaria tomentosa (Cat's claw) for aromatase inhibitor-induced arthralgia: a pilot study","volume":"19","author":"Sordi","year":"2019","journal-title":"Journal of Natural Remedies"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0045|cit45","unstructured":"A trial to determine the effect of glucosamine versus placebo on aromatase inhibitor induced arthralgia (joint pain) in postmenopausal women with early breast cancer who are on letrozole www.who.int\/trialsearch\/Trial2.aspx?TrialID=ACTRN12611000891921"},{"issue":"2","key":"10.1002\/14651858.CD013167.pub2-BIB0046|cit46","first-page":"862","article-title":"Combined use of vitamin D and omega-3 fatty acid in breast cancer patients might be more beneficial for reducing aromatase inhibitors-associated arthralgia","volume":"24","author":"Altundag","year":"2019","journal-title":"Journal of BUON"},{"issue":"5","key":"10.1002\/14651858.CD013167.pub2-BIB0047|cit47","first-page":"1","article-title":"Omega-3 fatty acids significantly reduced pain in obese patients with breast cancer","volume":"11","author":"Barbor","year":"2018","journal-title":"Oncology Nurse-APN\/PA"},{"issue":"3","key":"10.1002\/14651858.CD013167.pub2-BIB0048|cit48","first-page":"11","article-title":"Antidepressant may relieve joint pain from aromatase inhibitors","volume":"32","author":"Becze","year":"2017","journal-title":"ONS Voice"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0049|cit49","unstructured":"Effect of moxibustion therapy for aromatase inhibitor-induced arthralgia of postmenopausal breast cancer patients apps.who.int\/trialsearch\/Trial2.aspx?TrialID=KCT0003698"},{"issue":"9","key":"10.1002\/14651858.CD013167.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.3899\/jrheum.120179","article-title":"Nonsteroidal antiinflammatory drugs (NSAID) versus NSAID with hydroxychloroquine in treatment of chemotherapy-related arthropathy: open-label multicenter pilot study","volume":"39","author":"Kim","year":"2012","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0051|cit51","unstructured":"Placebo-controlled trial with vitamin D to prevent worsening\/relieve aromatase inhibitor-induced musculoskeletal symptoms in breast cancer patients clinicaltrials.gov\/ct2\/show\/NCT01809171"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0052|cit52","unstructured":"Trial of oral hyaluronic acid for the prevention of aromatase inhibitor-associated arthralgias clinicaltrials.gov\/ct2\/show\/NCT03384095"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0053|cit53","unstructured":"Japanese study for usefulness of vitamin E in reducing aromatase inhibitor-associated joint symptoms upload.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_his_list.cgi?recptno=R000005255"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0054|cit54","unstructured":"Omega-3 supplementation in prevention of aromatase inhibitor-induced toxicity in patients with stage I\u2013III breast cancer clinicaltrials.gov\/show\/NCT02831582"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0055|cit55","unstructured":"Curcumin in reducing joint pain in breast cancer survivors with aromatase inhibitor-induced joint disease clinicaltrials.gov\/ct2\/show\/NCT03865992"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0056|cit56","unstructured":"Vitamin B12 for aromatase inhibitors associated musculoskeletal symptoms in breast cancer clinicaltrials.gov\/ct2\/show\/NCT04205786"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0057|cit57","unstructured":"Randomized study of Sokei-Kakketsu-To for the reduction of aromatase inhibitor \u2013 associated joint symptoms in women with breast cancer upload.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000031481"},{"issue":"2","key":"10.1002\/14651858.CD013167.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0378-8741(02)00093-4","article-title":"Anti-inflammatory activity of two different extracts of Uncaria tomentosa (Rubiaceae)","volume":"81","author":"Aguilar","year":"2002","journal-title":"Journal of Ethnopharmacology"},{"issue":"8","key":"10.1002\/14651858.CD013167.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1200\/JCO.19.01203","article-title":"Dietary supplement use during chemotherapy and survival outcomes of patients with breast cancer enrolled in a Cooperative Group Clinical Trial (SWOG S0221)","volume":"38","author":"Ambrosone","year":"2020","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD013167.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1021\/np50064a002","article-title":"Plant metabolites. Structure and in vitro antiviral activity of quinovic acid glycosides from Uncaria tomentosa and Guettarda platypoda","volume":"52","author":"Aquino","year":"1989","journal-title":"Journal of Natural Products"},{"issue":"1-3","key":"10.1002\/14651858.CD013167.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pain.2005.06.031","article-title":"A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder","volume":"119","author":"Arnold","year":"2005","journal-title":"Pain"},{"issue":"10","key":"10.1002\/14651858.CD013167.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJMp0911494","article-title":"The missing voice of patients in drug-safety reporting","volume":"362","author":"Basch","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD013167.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","article-title":"Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial","volume":"34","author":"Basch","year":"2016","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD013167.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.2017.7156","article-title":"Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment","volume":"318","author":"Basch","year":"2017","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD013167.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s00520-017-3613-z","article-title":"Prevalence of aromatase inhibitor-induced arthralgia in breast cancer: a systematic review and meta-analysis","volume":"25","author":"Beckwee","year":"2017","journal-title":"Supportive Care in Cancer"},{"issue":"3","key":"10.1002\/14651858.CD013167.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/AAP.0b013e3181df2645","article-title":"Duloxetine: a review of its pharmacology and use in chronic pain management","volume":"35","author":"Bellingham","year":"2010","journal-title":"Regional Anaesthesia and Pain Medication"},{"issue":"4","key":"10.1002\/14651858.CD013167.pub2-BIB0067|cit67","first-page":"477","article-title":"Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials","volume":"170","author":"Bhandari","year":"2004","journal-title":"CMAJ"},{"issue":"1","key":"10.1002\/14651858.CD013167.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1589\/jpts.31.75","article-title":"Minimal clinically important difference for grip strength: a systematic review","volume":"31","author":"Bohannon","year":"2019","journal-title":"Journal of Physical Therapy Science"},{"issue":"13","key":"10.1002\/14651858.CD013167.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1200\/JCO.2000.18.13.2515","article-title":"Use of complementary\/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions","volume":"18","author":"Boon","year":"2000","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1472-6874-7-4","article-title":"Trends in complementary\/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005","volume":"7","author":"Boon","year":"2007","journal-title":"BMC Womens Health"},{"issue":"2","key":"10.1002\/14651858.CD013167.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/17425255.2017.1234605","article-title":"Molecular basis of aromatase inhibitor associated arthralgia: known and potential candidate genes and associated biomarkers","volume":"13","author":"Borrie","year":"2017","journal-title":"Journal of Expert Opinion on Drug Metabolism & Toxicology"},{"issue":"2","key":"10.1002\/14651858.CD013167.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/annonc\/mdy524","article-title":"Patient-reported outcomes (PROs) as a routine measure for cancer inpatients: the final missing piece of the puzzle?","volume":"30","author":"Brandt","year":"2019","journal-title":"Annals of Oncology"},{"issue":"1","key":"10.1002\/14651858.CD013167.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/cncr.30318","article-title":"Perceived barriers to treatment predict adherence to aromatase inhibitors among breast cancer survivors","volume":"123","author":"Brier","year":"2017","journal-title":"Cancer"},{"issue":"1","key":"10.1002\/14651858.CD013167.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10549-009-0692-7","article-title":"Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study","volume":"120","author":"Briot","year":"2010","journal-title":"Breast Cancer Research and Treatment"},{"issue":"3","key":"10.1002\/14651858.CD013167.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.breast.2007.01.011","article-title":"Aromatase inhibitor-associated arthralgia syndrome","volume":"16","author":"Burstein","year":"2007","journal-title":"Breast"},{"issue":"2","key":"10.1002\/14651858.CD013167.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1200\/JOP.18.00617","article-title":"Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: ASCO Clinical Practice Guideline Focused Update","volume":"15","author":"Burstein","year":"2019","journal-title":"Journal of Oncology Practice"},{"issue":"13","key":"10.1002\/14651858.CD013167.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/cncr.28016","article-title":"Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort","volume":"119","author":"Castel","year":"2013","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2147\/PROM.S47997","article-title":"Validity and reliability of the Patient-Reported Arthralgia Inventory: validation of a newly-developed survey instrument to measure arthralgia","volume":"6","author":"Castel","year":"2015","journal-title":"Patient Related Outcome Measures"},{"issue":"8","key":"10.1002\/14651858.CD013167.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1089\/acm.2008.0039","article-title":"The use of complementary and alternative medicine among Chinese women with breast cancer","volume":"14","author":"Chen","year":"2008","journal-title":"Journal of Alternative and Complementary Medicine"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.breast.2017.03.015","article-title":"Effect of acupuncture on aromatase inhibitor-induced arthralgia in patients with breast cancer: a meta-analysis of randomized controlled trials","volume":"33","author":"Chen","year":"2017","journal-title":"Breast"},{"issue":"4","key":"10.1002\/14651858.CD013167.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00198-007-0490-1","article-title":"Salmon calcitonin: a review of current and future therapeutic indications","volume":"19","author":"Chesnut","year":"2008","journal-title":"Osteoporosis International"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/1471-2407-13-401","article-title":"Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors","volume":"13","author":"Chim","year":"2013","journal-title":"BMC Cancer"},{"issue":"21","key":"10.1002\/14651858.CD013167.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1200\/JCO.2015.63.8619","article-title":"Treatment adherence and Its Impact on disease-free survival in the Breast International Group 1-98 Trial of tamoxifen and letrozole, alone and in sequence","volume":"34","author":"Chirgwin","year":"2016","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD013167.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.maturitas.2010.10.006","article-title":"25-Hydroxyvitamin D concentration, vitamin D intake and joint symptoms in postmenopausal women","volume":"68","author":"Chlebowski","year":"2011","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0085|cit85","unstructured":"Cleeland CS The Brief Pain Inventory: user guide, 2009 www.mdanderson.org\/documents\/Departments-and-Divisions\/Symptom-Research\/BPI_UserGuide.pdf"},{"issue":"10","key":"10.1002\/14651858.CD013167.pub2-BIB0086|cit86","first-page":"1471","article-title":"Clinical and biochemical effects of dietary fish oil supplements in rheumatoid arthritis","volume":"15","author":"Cleland","year":"1988","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0087|cit87","unstructured":"Cochrane Musculoskeletal Group Proposed outcomes musculoskeletal.cochrane.org\/proposed-outcomes"},{"issue":"25","key":"10.1002\/14651858.CD013167.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1200\/JCO.2007.10.7573","article-title":"Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer","volume":"25","author":"Crew","year":"2007","journal-title":"Journal of Clinical Oncology"},{"issue":"13","key":"10.1002\/14651858.CD013167.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1200\/JCO.2008.19.6162","article-title":"High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy","volume":"27","author":"Crew","year":"2009","journal-title":"Journal of Clinical Oncology"},{"issue":"31","key":"10.1002\/14651858.CD013167.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1200\/JCO.2011.40.2180","article-title":"L-carnitine supplementation for the management of fatigue in patients with cancer: an Eastern Cooperative Oncology Group phase III, randomized, double-blind, placebo-controlled trial","volume":"30","author":"Cruciani","year":"2012","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD013167.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1023\/B:BREA.0000025422.26148.8d","article-title":"Use of complementary and alternative medicine by Chinese women with breast cancer","volume":"85","author":"Cui","year":"2004","journal-title":"Breast Cancer Research and Treatment"},{"issue":"9","key":"10.1002\/14651858.CD013167.pub2-BIB0092|cit92","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003115.pub4","article-title":"Oral or transdermal opioids for osteoarthritis of the knee or hip","author":"Da Costa","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0093|cit93","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s) Cochrane Handbook for Systematic Reviews of Interventions\u00a0Version 6.2\u00a0(updated February\u00a02021). Cochrane, 2021"},{"issue":"1","key":"10.1002\/14651858.CD013167.pub2-BIB0094|cit94","first-page":"1","article-title":"The association of funding source on effect size in randomized controlled trials: 2013\u20132015 \u2013 a cross-sectional survey and meta-analysis","volume":"18","author":"Delgado","year":"2017","journal-title":"Trials"},{"issue":"4","key":"10.1002\/14651858.CD013167.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4103\/2229-3485.86879","article-title":"Patient-reported outcomes: a new era in clinical research","volume":"2","author":"Deshpande","year":"2011","journal-title":"Perspectives in Clinical Research"},{"issue":"3","key":"10.1002\/14651858.CD013167.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.pain.2009.08.019","article-title":"Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations","volume":"146","author":"Dworkin","year":"2009","journal-title":"Pain"},{"issue":"10001","key":"10.1002\/14651858.CD013167.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(15)61074-1","article-title":"Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials","volume":"386","author":"Early Breast Cancer Trialists' Collaborative Group (EBCTCG)","year":"2015","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0098|cit98","first-page":"1","article-title":"Dietary intake of fats and fatty acids for the United States population: 1999\u20132000","volume":"348","author":"Ervin","year":"2004","journal-title":"Advance Data"},{"issue":"9","key":"10.1002\/14651858.CD013167.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jclinepi.2004.01.012","article-title":"A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale","volume":"57","author":"Eton","year":"2004","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0100|cit100","unstructured":"Microsoft Excel Microsoft Corporation 2018"},{"issue":"2","key":"10.1002\/14651858.CD013167.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jpain.2009.06.007","article-title":"The clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: analyses of data from clinical trials of duloxetine in pain disorders","volume":"11","author":"Farrar","year":"2010","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0102|cit102","unstructured":"COX-2 selective (includes Bextra, Celebrex, and Vioxx) and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/cox-2-selective-includes-bextra-celebrex-and-vioxx-and-non-selective-non-steroidal-anti-inflammatory"},{"issue":"9","key":"10.1002\/14651858.CD013167.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1002\/art.21364","article-title":"Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation","volume":"52","author":"Felson","year":"2005","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0104|cit104","volume-title":"GLOBOCAN, Cancer Incidence and Mortality Worldwide","author":"Ferlay","year":"2012"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0105|cit105","doi-asserted-by":"crossref","unstructured":"Francis PA Regan MM Fleming GF Lang I Ciruelos E Bellet M Adjuvant ovarian suppression in premenopausal breast cancer New England Journal of Medicine 2015 372 5 436 46","DOI":"10.1056\/NEJMoa1412379"},{"issue":"2","key":"10.1002\/14651858.CD013167.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1803164","article-title":"Tailoring adjuvant endocrine therapy for premenopausal breast cancer","volume":"379","author":"Francis","year":"2018","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD013167.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/1534735418775821","article-title":"Traditional and complementary medicine use among Indigenous cancer patients in Australia, Canada, New Zealand, and the United States: a systematic review","volume":"17","author":"Gall","year":"2018","journal-title":"Integrative Cancer Therapies"},{"issue":"6","key":"10.1002\/14651858.CD013167.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1210\/jcem-51-6-1359","article-title":"Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis","volume":"51","author":"Gallagher","year":"1980","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1-2","key":"10.1002\/14651858.CD013167.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pain.2007.01.020","article-title":"A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain","volume":"129","author":"Goldberg","year":"2007","journal-title":"Pain"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0110|cit110","unstructured":"GRADEpro GDT GRADE Working Group, McMaster University 2014"},{"issue":"8","key":"10.1002\/14651858.CD013167.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/cncr.26526","article-title":"Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort","volume":"118","author":"Greenlee","year":"2012","journal-title":"Cancer"},{"issue":"4","key":"10.1002\/14651858.CD013167.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00520-012-1628-z","article-title":"Phase II study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer","volume":"21","author":"Greenlee","year":"2013","journal-title":"Supportive Care in Cancer"},{"issue":"11","key":"10.1002\/14651858.CD013167.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1200\/OP.20.00113","article-title":"Management of aromatase inhibitor-induced musculoskeletal symptoms","volume":"16","author":"Gupta","year":"2020","journal-title":"JCO Oncology Practice"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.breast.2019.12.017","article-title":"Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients","volume":"50","author":"Hack","year":"2020","journal-title":"Breast"},{"issue":"2","key":"10.1002\/14651858.CD013167.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/annonc\/mdt513","article-title":"COMPliance and Arthralgia in Clinical Therapy: the COMPACT trial, assessing the incidence of arthralgia, and compliance within the first year of adjuvant anastrozole therapy","volume":"25","author":"Hadji","year":"2014","journal-title":"Annals of Oncology"},{"issue":"2","key":"10.1002\/14651858.CD013167.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10549-007-9774-6","article-title":"Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors","volume":"111","author":"Henry","year":"2008","journal-title":"Breast Cancer Research and Treatment"},{"issue":"24","key":"10.1002\/14651858.CD013167.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.1002\/cncr.26230","article-title":"Pilot study of duloxetine for treatment of aromatase inhibitor-associated musculoskeletal symptoms","volume":"117","author":"Henry","year":"2011","journal-title":"Cancer"},{"issue":"9","key":"10.1002\/14651858.CD013167.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1200\/JCO.2011.38.0261","article-title":"Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer","volume":"30","author":"Henry","year":"2012","journal-title":"Journal of Clinical Oncology"},{"issue":"17","key":"10.1002\/14651858.CD013167.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1200\/JCO.2015.61.1004","article-title":"The power of the placebo in symptom management","volume":"33","author":"Henry","year":"2015","journal-title":"Journal of Clinical Oncology"},{"issue":"12","key":"10.1002\/14651858.CD013167.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/cncr.32024","article-title":"Association between body mass index and response to duloxetine for aromatase inhibitor-associated musculoskeletal symptoms in SWOG S1202","volume":"125","author":"Henry","year":"2019","journal-title":"Cancer"},{"issue":"2","key":"10.1002\/14651858.CD013167.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10549-010-1132-4","article-title":"Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer","volume":"126","author":"Hershman","year":"2011","journal-title":"Breast Cancer Research and Treatment"},{"issue":"17","key":"10.1002\/14651858.CD013167.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1200\/JCO.2014.59.5595","article-title":"Randomized multicenter placebo-controlled trial of omega-3 fatty acids for the control of aromatase inhibitor-induced musculoskeletal pain: SWOG S0927","volume":"33","author":"Hershman","year":"2015","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-3-319-16366-6_7","article-title":"Symptoms: aromatase inhibitor induced arthralgias","volume":"862","author":"Hershman","year":"2015","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"5","key":"10.1002\/14651858.CD013167.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2217\/pgs-2016-0205","article-title":"Germline genetic predictors of aromatase inhibitor concentrations, estrogen suppression and drug efficacy and toxicity in breast cancer patients","volume":"18","author":"Hertz","year":"2017","journal-title":"Pharmacogenomics"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0125|cit125","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0126|cit126","unstructured":"Higgins JP Eldridge S Li T Chapter 23: Including variants on randomized trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions\u00a0Version 6.0 (updated July 2019). Cochrane, 2019 Available from training.cochrane.org\/handbook\/archive\/v6"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0127|cit127","unstructured":"Higgins JP Deeks JJ Altman DG Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0128|cit128","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s).\u00a0Cochrane Handbook for Systematic Reviews of Interventions\u00a0Version 6.2\u00a0(updated February\u00a02021), Cochrane, 2021 Available from training.cochrane.org\/handbook"},{"issue":"3","key":"10.1002\/14651858.CD013167.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0130|cit130","unstructured":"Noone A Krapcho M Miller D Brest A Yu M Median age of cancer patients at diagnosis (2012\u20132016) SEER Cancer Statistics Review (CSR) 1975\u20132016 2019 seer.cancer.gov\/archive\/csr\/1975_2016\/. Table 1.11"},{"issue":"5","key":"10.1002\/14651858.CD013167.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1634\/theoncologist.2015-0349","article-title":"Patient-reported outcomes and early discontinuation in aromatase inhibitor-treated postmenopausal women with early stage breast cancer","volume":"21","author":"Kadakia","year":"2016","journal-title":"Oncologist"},{"issue":"3","key":"10.1002\/14651858.CD013167.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1179\/jmt.2009.17.3.163","article-title":"Global rating of change scales: a review of strengths and weaknesses and considerations for design","volume":"17","author":"Kamper","year":"2009","journal-title":"Journal of Manual & Manipulative Therapy"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/1471-2407-11-436","article-title":"The time since last menstrual period is important as a clinical predictor for non-steroidal aromatase inhibitor-related arthralgia","volume":"11","author":"Kanematsu","year":"2011","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1002\/14651858.CD013167.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3390\/nu10030368","article-title":"A review of the health benefits of cherries","volume":"10","author":"Kelley","year":"2018","journal-title":"Nutrients"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.maturitas.2018.09.005","article-title":"Therapeutic options for aromatase inhibitor-associated arthralgia in breast cancer survivors: a systematic review of systematic reviews, evidence mapping, and network meta-analysis","volume":"118","author":"Kim","year":"2018","journal-title":"Maturitas"},{"issue":"4","key":"10.1002\/14651858.CD013167.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.breast.2007.12.006","article-title":"Use of complementary therapies by Australian women with breast cancer","volume":"17","author":"Kremser","year":"2008","journal-title":"Breast"},{"issue":"7","key":"10.1002\/14651858.CD013167.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.2105\/AJPH.2004.047688","article-title":"Race\/ethnicity and women's use of complementary and alternative medicine in the United States: results of a national survey","volume":"96","author":"Kronenberg","year":"2006","journal-title":"American Journal of Public Health"},{"issue":"6","key":"10.1002\/14651858.CD013167.pub2-BIB0138|cit138","first-page":"2331","article-title":"Short-term and low-dose prednisolone administration reduces aromatase inhibitor-induced arthralgia in patients with breast cancer","volume":"32","author":"Kubo","year":"2012","journal-title":"Anticancer Research"},{"issue":"6","key":"10.1002\/14651858.CD013167.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s10552-017-0888-9","article-title":"Patterns and reasons for switching classes of hormonal therapy among women with early-stage breast cancer","volume":"28","author":"Kwan","year":"2017","journal-title":"Cancer Causes & Control"},{"issue":"11","key":"10.1002\/14651858.CD013167.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"e0187165","DOI":"10.1371\/journal.pone.0187165","article-title":"Quality of life and impact of pain in women treated with aromatase inhibitors for breast cancer. A multicenter cohort study","volume":"12","author":"Laroche","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1002\/14651858.CD013167.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"e60338","DOI":"10.1371\/journal.pone.0060338","article-title":"Traditional Chinese medicine in cancer care: a review of controlled clinical studies published in Chinese","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0142|cit142","unstructured":"Lilly Pharmaceuticals USA Highlights of prescribing information:\u00a0CYMBALTA (duloxetine delayed-release capsules), for oral use pi.lilly.com\/us\/cymbalta-pi.pdf"},{"issue":"2","key":"10.1002\/14651858.CD013167.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/annonc\/mds290","article-title":"Prospective study to assess fluid accumulation and tenosynovial changes in the aromatase inhibitor-induced musculoskeletal syndrome: 2-year follow-up data","volume":"24","author":"Lintermans","year":"2013","journal-title":"Annals of Oncology"},{"issue":"1","key":"10.1002\/14651858.CD013167.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10549-014-2986-7","article-title":"A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMI","volume":"146","author":"Lintermans","year":"2014","journal-title":"Breast Cancer Research and Treatment"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejca.2015.12.013","article-title":"Genetic variant in the osteoprotegerin gene is associated with aromatase inhibitor-related musculoskeletal toxicity in breast cancer patients","volume":"56","author":"Lintermans","year":"2016","journal-title":"European Journal of Cancer"},{"issue":"12","key":"10.1002\/14651858.CD013167.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1007\/s00520-015-2722-9","article-title":"Relations between arthralgia and fear of recurrence: results of a cross-sectional study of breast cancer patients treated with adjuvant aromatase inhibitors therapy","volume":"23","author":"Lopez","year":"2015","journal-title":"Supportive Care in Cancer"},{"issue":"17","key":"10.1002\/14651858.CD013167.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1200\/JCO.2008.19.6253","article-title":"Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis","volume":"27","author":"Loprinzi","year":"2009","journal-title":"Journal of Clinical Oncology"},{"issue":"9 Suppl","key":"10.1002\/14651858.CD013167.pub2-BIB0148|cit148","first-page":"Abstract P1","article-title":"Prevention of aromatase Inhibitor (AI)-induced joint symptoms with omega-3 fatty acid supplementation: a randomized placebo-controlled pilot study","volume":"75","author":"Lustberg","year":"2015","journal-title":"Cancer Research"},{"issue":"3","key":"10.1002\/14651858.CD013167.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10549-017-4559-z","article-title":"Randomized placebo-controlled pilot trial of omega 3 fatty acids for prevention of aromatase inhibitor-induced musculoskeletal pain","volume":"167","author":"Lustberg","year":"2018","journal-title":"Breast Cancer Research and Treatment"},{"issue":"16","key":"10.1002\/14651858.CD013167.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1002\/cncr.24419","article-title":"Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors","volume":"115","author":"Mao","year":"2009","journal-title":"Cancer"},{"issue":"1","key":"10.1002\/14651858.CD013167.pub2-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"R8","DOI":"10.1186\/bcr2813","article-title":"Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors","volume":"13","author":"Mao","year":"2011","journal-title":"Breast Cancer Research"},{"issue":"1","key":"10.1002\/14651858.CD013167.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s43019-020-00038-3","article-title":"Minimal clinically important difference of commonly used patient-reported outcome measures in total knee arthroplasty: review of terminologies, methods and proposed values","volume":"32","author":"Maredupaka","year":"2020","journal-title":"Knee Surgery & Related Research"},{"issue":"10","key":"10.1002\/14651858.CD013167.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1200\/JCO.19.03141","article-title":"Clinical cancer advances 2020: annual report on progress against cancer from the American Society of Clinical Oncology","volume":"38","author":"Markham","year":"2020","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0154|cit154","unstructured":"McKenzie JE Brennan SE Chapter 12: Synthesizing and presenting findings using other methods. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.2\u00a0(updated February\u00a02021). Cochrane, 2021 Available from training.cochrane.org\/handbook"},{"issue":"6","key":"10.1002\/14651858.CD013167.pub2-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/acr.20449","article-title":"Estimation of minimum clinically important difference for pain in fibromyalgia","volume":"63","author":"Mease","year":"2011","journal-title":"Arthritis Care & Research"},{"issue":"11","key":"10.1002\/14651858.CD013167.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/annonc\/mdl177","article-title":"Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer","volume":"17","author":"Moy","year":"2006","journal-title":"Annals of Oncology"},{"issue":"1","key":"10.1002\/14651858.CD013167.pub2-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1309\/4WV79N2GHJ3X1841","article-title":"Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers","volume":"123","author":"Nadji","year":"2005","journal-title":"American Journal of Clinical Pathology"},{"issue":"6","key":"10.1002\/14651858.CD013167.pub2-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/ajco.12845","article-title":"Efficacy of management strategies for aromatase inhibitor-induced arthralgia in breast cancer patients: a systematic review","volume":"14","author":"Nahm","year":"2018","journal-title":"Asia-Pacific Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0159|cit159","unstructured":"National Centre for Complementary and Integrative Health (NCCIH) Complementary, alternative, or integrative health: what\u2019s In a name? nccih.nih.gov\/health\/integrative-health"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0160|cit160","unstructured":"National Cancer Institute Drug dictionary: Blue Citrus-based herbal capsule www.cancer.gov\/publications\/dictionaries\/cancer-drug\/def\/blue-citrus-based-herbal-capsule"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0161|cit161","unstructured":"National Institute for Health and Care Excellence Osteoarthritis: care and management www.nice.org.uk\/guidance\/cg177"},{"issue":"6","key":"10.1002\/14651858.CD013167.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/annonc\/mdt037","article-title":"Aromatase inhibitor-induced arthralgia: a review","volume":"24","author":"Niravath","year":"2013","journal-title":"Annals of Oncology"},{"issue":"1","key":"10.1002\/14651858.CD013167.pub2-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.clbc.2017.10.009","article-title":"Vitamin D levels, vitamin D receptor polymorphisms, and inflammatory cytokines in aromatase inhibitor-induced arthralgias","volume":"18","author":"Niravath","year":"2018","journal-title":"Clinical Breast Cancer"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jclinepi.2018.05.007","article-title":"Minimum clinically important differences in chronic pain vary considerably by baseline pain and methodological factors: systematic review of empirical studies","volume":"101","author":"Olsen","year":"2018","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0165|cit165","unstructured":"OMERACT Outcome Measurement omeract.org\/"},{"issue":"4","key":"10.1002\/14651858.CD013167.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1200\/JCO.2007.11.5451","article-title":"Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer","volume":"26","author":"Partridge","year":"2008","journal-title":"Journal of Clinical Oncology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD013167.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1111\/j.1524-4733.2007.00275.x","article-title":"Patient-reported outcomes to support medical product labeling claims: FDA perspective","volume":"10","author":"Patrick","year":"2007","journal-title":"Value in Health"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1745-6215-15-171","article-title":"Effects of the traditional Chinese medicine Yi Shen Jian Gu granules on aromatase inhibitor-associated musculoskeletal symptoms: a study protocol for a multicenter, randomized, controlled clinical trial","volume":"15","author":"Peng","year":"2014","journal-title":"Trials"},{"issue":"2","key":"10.1002\/14651858.CD013167.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10549-013-2548-4","article-title":"Postdiagnosis supplement use and breast cancer prognosis in the After Breast Cancer Pooling Project","volume":"139","author":"Poole","year":"2013","journal-title":"Breast Cancer Research and Treatment"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0170|cit170","volume-title":"Emu oil for osteoarthritic hand pain [Masters thesis]","author":"Power","year":"2004"},{"issue":"10","key":"10.1002\/14651858.CD013167.pub2-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3816\/CBC.2007.n.038","article-title":"Aromatase inhibitor-associated arthralgia and\/ or bone pain: frequency and characterization in non-clinical trial patients","volume":"7","author":"Presant","year":"2007","journal-title":"Clinical Breast Cancer"},{"issue":"1","key":"10.1002\/14651858.CD013167.pub2-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10549-011-1644-6","article-title":"Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial","volume":"129","author":"Rastelli","year":"2011","journal-title":"Breast Cancer Research and Treatment"},{"issue":"10","key":"10.1002\/14651858.CD013167.pub2-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1007\/s00296-012-2416-2","article-title":"Role of glucosamine in the treatment for osteoarthritis","volume":"32","author":"Reginster","year":"2012","journal-title":"Rheumatology International"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0174|cit174","unstructured":"Review Manager 5 (RevMan 5) Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0175|cit175","unstructured":"Review Manager Web (RevMan Web) The Cochrane Collaboration 2021"},{"issue":"1","key":"10.1002\/14651858.CD013167.pub2-BIB0176|cit176","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008922.pub2","article-title":"Muscle relaxants for pain management in rheumatoid arthritis","author":"Richards","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.critrevonc.2017.01.010","article-title":"Management of aromatase inhibitor induced musculoskeletal symptoms in postmenopausal early breast cancer: a systematic review and meta-analysis","volume":"111","author":"Roberts","year":"2017","journal-title":"Critical Reviews in Oncology\/Hematology"},{"issue":"11","key":"10.1002\/14651858.CD013167.pub2-BIB0178|cit178","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013167","article-title":"Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer","author":"Roberts","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD013167.pub2-BIB0179|cit179","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012988.pub2","article-title":"Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer","author":"Roberts","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD013167.pub2-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1200\/JCO.2017.76.3250","article-title":"What is the role of symptom management and patient-reported outcomes in adherence to aromatase inhibitors?","volume":"36","author":"Rocque","year":"2018","journal-title":"Journal of Clinical Oncology"},{"issue":"15 Suppl","key":"10.1002\/14651858.CD013167.pub2-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1200\/jco.2011.29.15_suppl.533","article-title":"Etoricoxib and anastrozole in adjuvant early breast cancer: ETAN trial (phase III)","volume":"29","author":"Rosati","year":"2011","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1196\/annals.1351.021","article-title":"Inflammation and sex hormone metabolism","volume":"1069","author":"Schmidt","year":"2006","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0183|cit183","doi-asserted-by":"crossref","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14:\u00a0Completing 'Summary of findings' tables and grading the certainty of the evidence.\u00a0In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook 2019 375 402 10.1002\/9781119536604.ch14","DOI":"10.1002\/9781119536604.ch14"},{"issue":"9","key":"10.1002\/14651858.CD013167.pub2-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S1470-2045(08)70182-7","article-title":"Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis","volume":"9","author":"Sestak","year":"2008","journal-title":"Lancet Oncology"},{"issue":"3","key":"10.1002\/14651858.CD013167.pub2-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10549-018-4946-0","article-title":"Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927)","volume":"172","author":"Shen","year":"2018","journal-title":"Breast Cancer Research and Treatment"},{"issue":"1","key":"10.1002\/14651858.CD013167.pub2-BIB0186|cit186","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005614.pub2","article-title":"Chondroitin for osteoarthritis","author":"Singh","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"13","key":"10.1002\/14651858.CD013167.pub2-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2013.2813","article-title":"Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial","volume":"309","author":"Smith","year":"2013","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD013167.pub2-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s00393-015-0023-9","article-title":"Relative efficacy and tolerability of etoricoxib, celecoxib, and naproxen in the treatment of osteoarthritis: a Bayesian network meta-analysis of randomized controlled trials based on patient withdrawal","volume":"75","author":"Song","year":"2016","journal-title":"Zeitschrift fur Rheumatologie"},{"issue":"5","key":"10.1002\/14651858.CD013167.pub2-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/147323000403200501","article-title":"Effects of n-3 fatty acids on serum interleukin-6, tumour necrosis factor-alpha and soluble tumour necrosis factor receptor p55 in active rheumatoid arthritis","volume":"32","author":"Sundrarjun","year":"2004","journal-title":"Journal of International Medical Research"},{"issue":"2","key":"10.1002\/14651858.CD013167.pub2-BIB0190|cit190","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002946.pub2","article-title":"Glucosamine therapy for treating osteoarthritis","author":"Towheed","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-3-0348-0927-6_5","article-title":"Traditional medicinal oils sourced from birds: anti-inflammatories and potential immunoregulants","volume":"70","author":"Turner","year":"2015","journal-title":"Progress in Drug Research"},{"issue":"9","key":"10.1002\/14651858.CD013167.pub2-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/archdischild-2013-304037","article-title":"Blinding in pharmacological trials: the devil is in the details","volume":"98","author":"Wan","year":"2013","journal-title":"Archives of Disease in Childhood"},{"issue":"1","key":"10.1002\/14651858.CD013167.pub2-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10787-998-0001-9","article-title":"Emu oil(s): a source of non-toxic transdermal anti-inflammatory agents in Aboriginal medicine","volume":"6","author":"Whitehouse","year":"1998","journal-title":"Inflammopharmacology"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0194|cit194","unstructured":"World Health Organization WHO traditional medicine strategy: 2014\u20132023 apps.who.int\/iris\/bitstream\/handle\/10665\/92455\/9789241506090_eng.pdf?sequence=1"},{"issue":"2","key":"10.1002\/14651858.CD013167.pub2-BIB0195|cit195","first-page":"50","article-title":"Development and classification of an operational definition of complementary and alternative medicine for the Cochrane collaboration","volume":"17","author":"Wieland","year":"2011","journal-title":"Alternative Therapies in Health and Medicine"},{"issue":"0 11","key":"10.1002\/14651858.CD013167.pub2-BIB0196|cit196","first-page":"S86","article-title":"Measures applied to the assessment of fibromyalgia: Fibromyalgia Impact Questionnaire (FIQ), Brief Pain Inventory (BPI), the Multidimensional Fatigue Inventory (MFI-20), the MOS Sleep Scale, and the Multiple Ability Self-Report Questionnaire (MASQ; cognitive dysfunction)","volume":"63","author":"Williams","year":"2011","journal-title":"Arthritis Care & Research"},{"issue":"3","key":"10.1002\/14651858.CD013167.pub2-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3892\/etm.2011.233","article-title":"Anti-inflammatory effect of patchouli alcohol isolated from Pogostemonis Herba in LPS-stimulated RAW264.7 macrophages","volume":"2","author":"Xian","year":"2011","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013167.pub2-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2354.2006.00685.x","article-title":"Traditional Chinese medicine in cancer care: perspectives and experiences of patients and professionals in China","volume":"15","author":"Xu","year":"2006","journal-title":"European Journal of Cancer Care"},{"issue":"9","key":"10.1002\/14651858.CD013167.pub2-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s12032-014-0128-z","article-title":"Aromatase inhibitors associated musculoskeletal disorders and bone fractures in postmenopausal breast cancer patients: a result from Chinese population","volume":"31","author":"Xu","year":"2014","journal-title":"Medical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD013167.pub2-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"E26","DOI":"10.1097\/NCC.0000000000000409","article-title":"Interventions for the treatment of aromatase inhibitor-associated arthralgia in breast cancer survivors: a systematic review and meta-analysis","volume":"40","author":"Yang","year":"2017","journal-title":"Cancer Nursing"},{"key":"10.1002\/14651858.CD013167.pub2-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1472-6920-14-13","article-title":"Evaluating the impact of an intensive education workshop on evidence-informed decision making knowledge, skills, and behaviours: a mixed methods study","volume":"14","author":"Yost","year":"2014","journal-title":"BMC Medical Education"},{"issue":"6","key":"10.1002\/14651858.CD013167.pub2-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/COC.0b013e3181cae782","article-title":"Immunological therapies can relieve aromatase inhibitor-related joint symptoms in breast cancer survivors","volume":"33","author":"Zhang","year":"2010","journal-title":"American Journal of Clinical Oncology"},{"issue":"11","key":"10.1002\/14651858.CD013167.pub2-BIB0203|cit203","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013167","article-title":"Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer","author":"Roberts","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T14:19:12Z","timestamp":1713104352000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013167.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Breast Cancer Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":203,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013167.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,10]]}}}